Effect of Methylene Blue in treatment of Coronavirus Patients

Phase 1

Recruiting

• Conditions: coronavirus infection.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20211012052735N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients are to be free of any underlying disorders.
Patients are to be free of any kidney (creatinine test), liver (liver and LFT tests), and heart damages.
The age of inclusion in the study is to be between 20-50 years
Nasopharyngeal RT-PCR test sample is to be positive
Diagnosed with lung damages through CT scan
Have no history of viral infections with hepatitis and AIDS
Have not had received recombinant treatments
Have not had G6PD enzyme defect
O2Saturation of patients is to be less or equal to 85

Exclusion Criteria

Pregnant women and women who are planning to become pregnant
Breastfeeding women
People with a history of allergies to methylene blue
People with a BMI above 30
People with kidney, heart, lung disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood O2 saturation. Timepoint: daily. Method of measurement: saturation %.